Table 4.
Results from dose plan analysis for Patient 3
| Obj. | HT | IMP | RA | |
| PTVII | ||||
| Mean [Gy] | 42.5 | 42.5 (100%) |
42.5 (100%) |
42.5 (100%) |
| D1% [%] | - | 102.4 | 106.1 | 103.5 |
| D99% [%] | - | 94.8 | 83.8 | 94.1 |
| V90% [%] | 100% | 100.0 | 97.9 | 100.0 |
| V95% [%] | 100% | 98.9 | 95.6 | 100.0 |
| V107% [%] | 0% | 0.0 | 0.5 | 0. |
| V110% [%] | 0% | 0. | 0. | 0. |
| D5–D95 [%] | - | 4.0 | 8.2 | 6.1 |
| SD [%] | - | 1.2 | 3.8 | 1.9 |
| CI90 | 1.0 | 1.0 | 1.0 | 1.2 |
| PTVI-PTVII | ||||
| Mean [Gy] | 30.6 | 31.3 (102.3%) |
31.3 (102.3%) |
31.5 (102.9%) |
| D1% [%] | - | 126.5 | 122.4 | 130.4 |
| D99% [%] | - | 89.9 | 95.8 | 94.8 |
| V90% [%] | 100% | 98.9 | 99.6 | 100. |
| V95% [%] | 100% | 96.7 | 99.2 | 100. |
| V107% [%] | 0% | 9.7 | 6.6 | 8.3 |
| V110% [%] | 0% | 5.4 | 2.9 | 5.2 |
| D5–D95 [%] | - | 13.4 | 9.5 | 14.0 |
| SD [%] | - | 5.2 | 4.6 | 5.6 |
| Spinal Cord | ||||
| D1% [Gy] | < 45 Gy | 31.8 | 29.4 | 32.3 |
| Right Eye | ||||
| Mean [Gy] | < 15 Gy | 15.3 | 12.2 | 12.3 |
| V20 Gy [%] | Minim | 29.2 | 24.3 | 15.3 |
| D1% [Gy] | Minim | 36.8 | 34.6 | 30.5 |
| Right Lens | ||||
| Mean [Gy] | < 15 Gy | 11.8 | 1.9 | 7.9 |
| D1% [Gy] | Minim | 18.4 | 2.7 | 10.2 |
| Healthy tissue | ||||
| Mean Gy] | Minim | 17.3 | 14.2 | 15.7 |
| V10 Gy [cm3] | Minim | 74.3 | 56.9 | 62.7 |
| EI [%] | Minim | 0.1 | 0.1 | 0.0 |
| DosInt [105 *Gy*cm3] | Minim | 0.25 | 0.20 | 0.23 |